Search for Clinical Trial Results
Leukemia, T-cell, Chronic - 25 Studies Found
Status | Study |
Completed |
Study Name: Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia Condition: Leukemia, T-Cell Date: 2004-11-03 Interventions: Drug: forodesine hydrochloride (BCX-1777) |
Completed |
Study Name: RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma Condition:
Date: 2004-04-23 Interventions: Drug: RAD001 Phase I: Starting dose 5 mg by mouth daily fo |
Completed |
Study Name: Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1 Condition: Human T-Lymphoma Virus Type I Date: 2006-06-19 |
Withdrawn |
Study Name: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia Condition:
Date: 2010-07-12 Interventions: Drug: Velcade IV Other Name: Bortezomib |
Completed |
Study Name: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma Condition: Leukemia-Lymphoma, Adult T-Cell Date: 2009-10-19 Interventions:
|